How can clinicians ensure patients at high risk of breast cancer recurrence are identified and considered for appropriate adjuvant treatment? In this episode of Embracing the Challenge – advancing cancer care, host Dr Anu Agarwal joins Professor Javier Cortés and Associate Professor Sanjay Warrier to explore the evolving treatment landscape in hormone receptor-positive early breast cancer. The discussion examines the importance of accurate nodal assessment, tumour grade and tumour size, and how these details inform risk assessment and treatment access in Australian practice. This episode is for members only. Please go to https://www.pcpa.org.au/member-login/ to access.